Latest PLX reports update at 2024-03-14: 202320222021
Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.21 5.22%

Protalix BioTherapeutics Financial Statements 2011-2024 | PLX

Annual Financial Statements Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

92.5 M 93.1 M 37.1 M 128 M 50.6 M 61.8 M 90.4 M 61.8 M 80.7 M 186 M 405 M 457 M 461 M

Shares

67.5 M 48.5 M 44.1 M 29.1 M 14.8 M 14.7 M 13.1 M 10.1 M 9.49 M 9.29 M 9.24 M 9.08 M 8.46 M

Historical Prices

1.37 1.92 0.84 4.38 3.7 4.9 6.9 6.3 8.5 20 42.5 51.1 56.8

Net Income

8.31 M -14.9 M -27.6 M -6.52 M -18.3 M -26.5 M -85.3 M -29.4 M 58 M -29.9 M -27.8 M -11.6 M -36.5 M

Revenue

65.5 M 47.6 M 38.4 M 62.9 M 54.7 M 34.2 M 19.2 M 9.2 M 4.36 M 15.2 M 11.5 M 34.4 M 8.39 M

Cost of Revenue

23 M 19.6 M 16.3 M 10.9 M 10.9 M 9.3 M 15.2 M 8.4 M 730 K 630 K - 8.14 M 1.52 M

Gross Profit

- - - - 43.8 M 24.9 M 4.01 M 801 K 3.63 M 6.11 M 6.08 M 26.3 M 1.44 M

Operating Income

10.5 M -13 M -20.5 M 2.71 M -10.7 M -19.3 M -34.5 M -33.2 M -23.7 M -28.6 M -34.1 M -12.2 M -36.5 M

Interest Expense

- - - - - - - - 3.55 M 3.55 M 1.02 M - -

EBITDA

11.7 M -11.9 M -19.3 M 4.01 M -9.1 M -17.6 M -34.4 M -31.2 M -21.3 M -22.1 M -23.6 M -8.48 M -32.9 M

Operating Expenses

- - - - 54.5 M 44.2 M 40.4 M 34 M 27.3 M 31.3 M 33.2 M 38.5 M 38 M

General and Administrative Expenses

15 M 11.7 M 12.7 M 11.1 M 9.9 M 10.9 M 11.5 M 9.36 M 7.28 M 9.66 M 8.38 M 9.76 M 6.93 M

All numbers in USD currency

Quarterly Income Statement Protalix BioTherapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

72.3 M 67.2 M 57.5 M - 49.5 M 47.3 M 45.8 M 45.6 M 45.6 M 45.4 M 39.9 M 34.8 M 32.9 M 32.4 M 17.4 M 14.8 M 14.8 M 14.8 M 14.8 M 14.8 M 148 M 147 M 145 B 144 M 133 M 128 M 124 M 124 M 99.8 M 99.8 M 99.7 M 99.8 M 93.9 M 93.6 M 93.2 M 93.6 M 93 M 92.8 M 92.7 M 93.6 M 92.4 M 92.3 M 92.2 M 93.5 M 91.9 M 91.5 M 87.8 M 85.6 M 85.6 M 85.6 M -

Net Income

-1.85 M 19.3 M -3.13 M - -3.57 M -5.33 M -2.29 M - -4.2 M -11.2 M -5.48 M - -4.44 M -4.15 M 1.67 M 291 K -3.56 M -7.74 M -7.26 M -5.43 M -5.32 M -8.46 M -7.24 M - -11.4 M 450 K -59.1 M - -7.29 M -10.9 M -8.6 M - -3.82 M -5.07 M -5.97 M - -8.01 M -6.12 M -7.34 M - -5.75 M -6.84 M -4.32 M - -5.48 M 9.64 M -5.9 M - -8.88 M -13.7 M -5.05 M

Revenue

10.3 M 35.1 M 9.59 M - 14.2 M 8.75 M 16.1 M - 12.1 M 6.43 M 11.3 M - 10.8 M 11 M 21.6 M - 14.2 M 12.2 M 10.4 M - 663 K 2.01 M 4.55 M - 7.53 M 6.36 M 2.89 M - 4.67 M 1.77 M 679 K - 1.34 M 1.34 M 1.69 M - 2.4 M 2.42 M 6.7 M - 2.28 M 2.26 M 3.57 M - 3.72 M 26.1 M 3.86 M - 1.13 M 764 K 4.13 M

Cost of Revenue

4.89 M 6.15 M 3.08 M - 7.07 M 4.09 M 6.03 M - 3.7 M 4.73 M 4.76 M - 2.87 M 1.83 M 3.43 M - 3.2 M 2.7 M 2.04 M - 1.92 M 2.18 M 2.92 M - 6.07 M 5.52 M 2.09 M - 4.25 M 1.68 M 523 K - 223 K 225 K 282 K - 1.8 M 1.6 M 4.07 M - 1.59 M 1.32 M 971 K - 2.37 M 3.28 M 1.32 M - 220 K 132 K 778 K

Gross Profit

- - - - - - - - - - - - - - - - - - - - -1.25 M -177 K 1.63 M - 1.46 M 835 K 801 K - 422 K 94 K 156 K - 1.11 M 1.11 M 1.41 M - 1.91 M 1.08 M 3.31 M - 1.77 M 1.75 M 3 M - 3.02 M 22 M 2.41 M - 677 K -4.75 M 5.22 M

Operating Income

-1.89 M 20.4 M -2.46 M - -3.12 M -5.52 M -1.87 M - -1.88 M -9.17 M -3.7 M - -2.58 M -2.24 M 4.69 M 2.2 M -1.54 M -5.84 M -5.53 M -3.67 M -3.74 M -6.74 M -5.15 M - -7.76 M -10.8 M -6.36 M - -6.65 M -9.93 M -7.86 M - -5 M -5.58 M -5.38 M - -6.21 M -5.45 M -6.47 M - -5.64 M -6.89 M -4.43 M - -5.56 M 9.62 M -6.06 M - -8.77 M -13.9 M -5.04 M

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 119 K - - - - - - - - - -

EBITDA

- - -2.18 M - -2.31 M -4.99 M -1.6 M - -1.03 M -8.59 M -3.42 M - -1.57 M -1.53 M 5.07 M 2.2 M -339 K -5.06 M -5.13 M -3.67 M -2.48 M -5.9 M -4.72 M - -6.3 M -9.82 M -5.87 M - -5.16 M -8.92 M -7.35 M - -3.19 M -4.36 M -4.77 M - -3.79 M -3.82 M -5.64 M - -5.64 M -6.89 M -4.43 M - -5.56 M 9.62 M -6.06 M - -8.77 M -13.9 M -5.04 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

3.67 M 4.03 M 3.12 M - 2.85 M 2.61 M 3.15 M - 2.95 M 3.17 M 3.14 M - 2.82 M 2.19 M 3.19 M - 2.59 M 2.07 M 2.23 M - 4.09 M 2.16 M 2.5 M - 2.84 M 2.81 M 2.54 M - 2.01 M 2.21 M 2 M - 2.16 M 2 M 1.82 M - 2.01 M 1.57 M 3.71 M - 1.78 M 2.18 M 2.1 M - 2.22 M 3.5 M 1.63 M - 1.53 M 1.8 M 1.99 M

All numbers in USD currency